Advancements in development of novel class of HIV protease inhibitors
Background Protease (PR) inhibitors (PIs) are widely regarded as the most significant agents in the treatment of human immunodeficiency virus (HIV) and have been instrumental in the success of highly active antiretroviral therapy (HAART). The PR enzyme is essential for the viral life cycle, as it cl...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2026-12-01
|
| Col·lecció: | Annals of Medicine |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/07853890.2026.2617730 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|